Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06848686 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Prevention Ambassadors: Intervention to Promote HIV Service Engagement in the Networks of SSP Clients

StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary endpoints: details revised at 2 of 3 entries Show 5 more changesShow less
    • Trial completed
    • Final enrollment: 170 participants (planned 210)
    • Study completion date changed from estimate of Feb 2027 to Aug 14, 2026
    • Eligibility criteria expanded, about 9 words
    • Site details revised
  2. Primary completion date: Dec 2025 to Jul 2026
    • Enrollment target: 150 to 210
    • Study completion date: Feb 2026 to Feb 2027
    v3
  3. Collaborators: 3 to 4v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
HIV testing and service uptake are infrequent among people who use drugs (PWUD) in the United States. In partnership with a community-based syringe service program (SSP), this project will develop the SSP-based "Prevention Ambassadors" (PA) intervention to promote HIV testing and service uptake among PWUD via the secondary distribution (i.e., peer delivery) of HIV self-testing (HIVST) kits with local HIV service information and referrals to HIV service navigation in the social networks of SSP clients (i.e., PWUD). The PA intervention will then be piloted to assess its preliminary effects, acceptability, and feasibility among PWUD in the Ending the HIV Epidemic priority jurisdiction of Riverside County, California.
Trial Details
NCT Number NCT06848686
Lead Sponsor San Diego State University
Collaborators: University of California, San Diego, University of California, Riverside, Dap Health, National Institute on Drug Abuse (NIDA)
Conditions
(from sponsor)		 HIV
Enrollment 170 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov